Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.

about

Surgical management of neuroendocrine tumor-associated liver metastases: a review.

P2860

Q55408892-1DAD9015-A73E-4546-9111-FEF513E46A43

P2860

Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.

Item

http://www.wikidata.org/entity/Q38668755

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Early Recurrence of Neuroendoc ...... ors, Prognosis, and Treatment.

@en

type

Item

label

Early Recurrence of Neuroendoc ...... ors, Prognosis, and Treatment.

@en

prefLabel

Early Recurrence of Neuroendoc ...... ors, Prognosis, and Treatment.

@en

P1476

Early Recurrence of Neuroendoc ...... ors, Prognosis, and Treatment.

@en

P2093

George A Poultsides

http://www.w3.org/2001/XMLSchema#string

Jeffery Chakedis

http://www.w3.org/2001/XMLSchema#string

Luca Aldrighetti

http://www.w3.org/2001/XMLSchema#string

Matthew Weiss

http://www.w3.org/2001/XMLSchema#string

Ryan C Fields

http://www.w3.org/2001/XMLSchema#string

Shishir Kumar Maithel

http://www.w3.org/2001/XMLSchema#string

Todd W Bauer

http://www.w3.org/2001/XMLSchema#string

Xu-Feng Zhang

http://www.w3.org/2001/XMLSchema#string

Yi Lv

http://www.w3.org/2001/XMLSchema#string

P2860

Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases

Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours

Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis.

Neuroendocrine liver metastasis: The chance to be cured after liver surgery.

Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.

Predictors of early recurrence after resection of colorectal liver metastases.

Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.

Prognostic factors in gastrointestinal endocrine tumors.

Early Recurrence After Hepatectomy for Colorectal Liver Metastases: What Optimal Definition and What Predictive Factors?

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

P2888

s11605-017-3490-2

P31

scholarly article

P356

10.1007/S11605-017-3490-2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28730354

http://www.w3.org/2001/XMLSchema#string

P921

hepatectomy

Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.

about

P2860

P2860

Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P50

P577

P698

P921